Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $75.2B
1-Year Return 41.49%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Quarter Return
-3.47%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$85.2B
AUM Growth
+$4.83B
Cap. Flow
+$7.85B
Cap. Flow %
9.22%
Top 10 Hldgs %
12.02%
Holding
4,686
New
824
Increased
1,559
Reduced
1,626
Closed
654

Sector Composition

1 Healthcare 18.68%
2 Technology 14.97%
3 Consumer Discretionary 11.35%
4 Consumer Staples 10.73%
5 Communication Services 8.95%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
USIG icon
2676
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$15.2B
$1.08M ﹤0.01%
+19,700
New +$1.08M
MNA icon
2677
IQ ARB Merger Arbitrage ETF
MNA
$256M
$1.08M ﹤0.01%
33,905
+25,105
+285% +$802K
YMAB icon
2678
Y-mAbs Therapeutics
YMAB
$1.08M ﹤0.01%
91,000
-7,600
-8% -$90.3K
JAGX icon
2679
Jaguar Health
JAGX
$4.05M
$1.08M ﹤0.01%
+14
New +$1.08M
MNTS icon
2680
Momentus
MNTS
$13.8M
$1.08M ﹤0.01%
483
+176
+57% +$393K
ELA icon
2681
Envela
ELA
$192M
$1.08M ﹤0.01%
231,184
-44,806
-16% -$209K
ALTG icon
2682
Alta Equipment Group
ALTG
$229M
$1.07M ﹤0.01%
86,600
+14,000
+19% +$173K
CHCI icon
2683
Comstock Holding Companies
CHCI
$157M
$1.07M ﹤0.01%
179,364
-3,800
-2% -$22.7K
NRIX icon
2684
Nurix Therapeutics
NRIX
$655M
$1.07M ﹤0.01%
+76,200
New +$1.07M
AMPE
2685
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$1.07M ﹤0.01%
7,559
-449
-6% -$63.3K
CGW icon
2686
Invesco S&P Global Water Index ETF
CGW
$1B
$1.06M ﹤0.01%
20,300
+4,971
+32% +$261K
AXGN icon
2687
Axogen
AXGN
$774M
$1.06M ﹤0.01%
+133,900
New +$1.06M
SCPH icon
2688
scPharmaceuticals
SCPH
$302M
$1.06M ﹤0.01%
186,086
-2,900
-2% -$16.5K
BWIN
2689
Baldwin Insurance Group
BWIN
$2.24B
$1.06M ﹤0.01%
+39,400
New +$1.06M
BNR
2690
Burning Rock Biotech
BNR
$89M
$1.06M ﹤0.01%
11,360
-5,179
-31% -$481K
GCMG icon
2691
GCM Grosvenor
GCMG
$685M
$1.06M ﹤0.01%
108,600
-143,181
-57% -$1.39M
OLMA icon
2692
Olema Pharmaceuticals
OLMA
$532M
$1.05M ﹤0.01%
+247,332
New +$1.05M
SPHQ icon
2693
Invesco S&P 500 Quality ETF
SPHQ
$15.3B
$1.05M ﹤0.01%
21,100
-6,100
-22% -$304K
ASLE icon
2694
AerSale
ASLE
$393M
$1.05M ﹤0.01%
66,900
-4,300
-6% -$67.6K
HARP
2695
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$1.05M ﹤0.01%
21,120
+15,960
+309% +$793K
BOH icon
2696
Bank of Hawaii
BOH
$2.66B
$1.05M ﹤0.01%
12,500
-20,800
-62% -$1.75M
ABCB icon
2697
Ameris Bancorp
ABCB
$5.09B
$1.05M ﹤0.01%
+23,869
New +$1.05M
FVCB icon
2698
FVCBankcorp
FVCB
$240M
$1.05M ﹤0.01%
63,099
-1,026
-2% -$17K
FDMT icon
2699
4D Molecular Therapeutics
FDMT
$311M
$1.05M ﹤0.01%
69,100
+24,300
+54% +$367K
GRTX
2700
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$1.05M ﹤0.01%
+439,134
New +$1.05M